1. Anti-infection Metabolic Enzyme/Protease
  2. Parasite Aminopeptidase
  3. Antimalarial agent 55

Antimalarial agent 55 是一种口服有效的恶性疟原虫 PfA-M1 PfA-M17 氨肽酶抑制剂,其 Ki 分别为 27 和 81 nM。Antimalarial agent 55 对间日疟和伯氏疟原虫同源酶均表现出纳摩尔级的强效活性,其对于 Pv-M1Pb-M1Pv-M17Pb-M17Ki 值分别为 2、4、190 和 18 nM。Antimalarial agent 55 具有显著的抗疟原虫活性,且具备交叉物种抑制能力和不受现有耐药机制影响的广谱活性。Antimalarial agent 55 可用于疟疾的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Antimalarial agent 55

Antimalarial agent 55 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

查看 Parasite 亚型特异性产品:

查看 Aminopeptidase 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Antimalarial agent 55 is an orally potent inhibitor of PfA-M1 and PfA-M17 aminopeptidases from Plasmodium falciparum, with Ki values of 27 nM and 81 nM, respectively. Antimalarial agent 55 exhibits potent nanomolar activity against homologous enzymes from Plasmodium vivax and Plasmodium berghei, with Ki values of 2 nM, 4 nM, 190 nM and 18 nM for Pv-M1, Pb-M1, Pv-M17 and Pb-M17, respectively. Antimalarial agent 55 possesses significant antiplasmodial activity, as well as cross-species inhibitory capacity and broad-spectrum activity that is unaffected by existing drug resistance mechanisms. Antimalarial agent 55 can be used in malaria research[1].

体外研究
(In Vitro)

Antimalarial agent 55 (Compound 3k) (72 h) 对恶性疟原虫株 Pf3D7 具有体外杀伤活性,其 EC50 为 31 nM;对不同耐药机制的恶性疟原虫临床分离株同样有着强效的活性。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

药代动力学
(Parmacokinetics)
Species Dose Route Clearance (CL) T1/2 Vss B/P Bioavailability Cmax Tmax
Mice[1] 1 mg/kg i.v. 36.1 mL/min/kg 0.86 h 0.447 L/kg 0.75 / / /
Mice[1] 3 mg/kg p.o. / 11 h / / 61.8 % 2.04 μM 0.25 h
Mice[1] 50 mg/kg p.o. / 7.2 h / / 63.4 % 20 μM 0.25 h
体内研究
(In Vivo)

Antimalarial agent 55 (Compound 3k) (50 mg/kg; p.o.; 4 次给药) 对感染 Plasmodium berghei 的瑞士小鼠,在感染后第 3 天可实现 100% 的抗疟活性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Arc:Arc(Swiss) (female, 6-weeks of age, intraperitoneal infection with 2 × 107 Plasmodium berghei ANKA-infected erythrocytes)[1]
Dosage: 50 mg/kg
Administration: p.o.; at 2 h, day 1, day 2, and day 3 postinfection
Result: Achieved 100% antimalarial activity at 3 days post-infection.\nAchieved 83% antimalarial activity at 4 days post-infection.\nAchieved 63% antimalarial activity at 6 days post-infection.
分子量

315.37

Formula

C17H21N3O3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Antimalarial agent 55
目录号:
HY-181266
需求量: